Kevin Lynch is the founder of Antengene Corporation. Antengene Corporation has raised $141M in total funding. Latest round: Series B.
Kevin Lynch was appointed as the Chief Medical Officer (CMO) of Antengene Corporation in March 2021. He brings nearly 30 years of experience in pharmaceutical R&D, having held national, regional, and global clinical roles at companies like Novartis and Celgene.
Full founder directory · Investor directory · Company funding database · Fundraising library